Your browser doesn't support javascript.
loading
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
Gunatilake, Samal; Brims, Fraser J H; Fogg, Carole; Lawrie, Iain; Maskell, Nick; Forbes, Karen; Rahman, Najib; Morris, Steve; Ogollah, Reuben; Gerry, Stephen; Peake, Mick; Darlison, Liz; Chauhan, Anoop J.
Affiliation
  • Gunatilake S; RESPECT Meso trial co-ordinator, Portsmouth Hospitals NHS Trust, Portsmouth, England. drsgunatilake@gmail.com.
Trials ; 15: 367, 2014 Sep 19.
Article in En | MEDLINE | ID: mdl-25238873
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Pleural Neoplasms / Quality of Life / Referral and Consultation / Research Design / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspects: Patient_preference Country/Region as subject: Europa Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Pleural Neoplasms / Quality of Life / Referral and Consultation / Research Design / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspects: Patient_preference Country/Region as subject: Europa Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom